Vaxcyte, Inc. (PCVX) bonds
PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$64.69−3.93 (-5.73%)
Close on Nov 12, 2026Market cap $9.63BP/E –Yield 0.00%
Debt
Borrowings on the balance sheet, Sep 30, 2026
Vaxcyte reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
Individual notes, bonds and loans
Vaxcyte's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?